跳至主要内容
临床试验/NL-OMON50646
NL-OMON50646尚未招募不适用

CONvalescence of FUnCtional outcomes after ICU Stay by oral protein supplementation The CONFUCIUS oral protein supplementation trial - CONFUCIUS oral protein supplementation trial

Ziekenhuisvoorzieningen Gelderse Vallei0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age >= 18 years
  • 2. Living at home before hospital admission
  • 3. Minimum ICU stay of 72 h
  • 4. Informed consent

排除标准

  • 1. MRC sum score <= 24 or 48 >= at ICU discharge
  • 2. Barthel Index <14 before ICU admission
  • 3. Allergy/intolerance for study product
  • 4. Serum creatinin > 173 mcmol/l (renal dysfunction)
  • 5. Inclusion in other intervention trial since ICU admission
  • 6. Inflammatory Bowel Disease
  • 7. Zwangerschap
  • 8. Underlying disease in which in the eyes of the attending physician, the
  • protein or carbohydate supplement could form a risk for the patient

研究者

发起方
Ziekenhuisvoorzieningen Gelderse Vallei

相似试验

CONvalescence of FUnCtional outcomes after ICU Stay... | 临床试验